0,00 €
0
🔥 Metabolic & Fat Loss

Tirzepatide

GIP/GLP-1 dual agonist · dual incretin receptor agonist

A dual agonist of GIP and GLP-1 receptors researched for its combined effects on glucose regulation and appetite signalling.

Type
GIP/GLP-1 agonist
Common sizes
10 mg · 20 mg
Research focus
Dual incretin signalling
Often studied with
Semaglutide · Cagrilintide
🧬

What is Tirzepatide?

Tirzepatide is a synthetic peptide that activates both the GIP and GLP-1 receptors. Research examines how this dual incretin mechanism influences insulin signalling, glucose handling, and appetite regulation, and how the combined receptor activity compares with single-receptor agonists in metabolic model systems.

It is a widely studied dual-agonist reference compound. It is used strictly as a research reagent.

🔬

Areas of research

🎯

Dual agonism

Studied for simultaneous activation of GIP and GLP-1 receptor pathways.

🩸

Glucose signalling

Researched for effects on insulin secretion and glucose handling in metabolic models.

🍽️

Appetite regulation

Examined for incretin-mediated influence on appetite and satiety pathways.

⚖️

Metabolic modelling

Investigated as a reference for comparing dual- versus single-receptor mechanisms.

💧

In the lab: reconstitution

1

Bring the vial (10 mg · 20 mg) and bacteriostatic water to room temperature.

2

Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.

3

Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.

Tip: The Peptide Calculator converts any vial size and water volume into units per syringe mark automatically.

Full storage & handling guide →

🧩

Commonly researched combinations

🔗

Tirzepatide + Cagrilintide

Studied together to model incretin agonism alongside amylin-receptor appetite signalling.

View stack →
📊

Tirzepatide + Semaglutide

Compared in research contrasting dual- versus single-receptor incretin mechanisms.

View stack →
📚

Selected research studies

Tirzepatide — tirzepatide GIP GLP-1 dual agonistPubMed ↗
Tirzepatide — tirzepatide glucose insulinPubMed ↗
Tirzepatide — tirzepatide appetite metabolismPubMed ↗

Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.

💬

FAQ

What is Tirzepatide?

It is a synthetic dual agonist activating both GIP and GLP-1 receptors, researched for its combined effects on insulin signalling, glucose handling, and appetite regulation in metabolic model systems.

How does dual agonism matter?

Research examines whether simultaneous GIP and GLP-1 receptor activation produces effects distinct from single-receptor agonists, making Tirzepatide a key reference for incretin-mechanism studies.

Is it a research-only compound here?

Yes. In this context it is handled as a research reagent for laboratory and preclinical metabolic studies, with no approved clinical or therapeutic application.

Explore Tirzepatide

See the product, or build a stack around it.

View product →Open Stack-Builder →
For laboratory research only. This guide is provided solely for scientific orientation. Tirzepatide and all products are not intended for human or animal use, nor for the diagnosis, treatment or prevention of any disease. Nothing here is dosing guidance.
© Nephiz Labs · Peptide Guide: Tirzepatide
Research-use information
Shop
Search
Account
Cart
0
Your Cart (0)
Empty CartYour cart is emptyReturn to Shop
Secure Checkout Secure Checkout
Premium Quality Premium Quality
Fast Shipping Fast Shipping